[HTML][HTML] Insights into therapy resistance in cervical cancer

IA George, R Chauhan, RE Dhawale, R Iyer… - Advances in Cancer …, 2022 - Elsevier
… involved in the development of treatment resistance in cancer. In this review, we summarise
the different mechanisms of treatment resistance in cervical cancer. We primarily focus on …

The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival

EA Kidd, BA Siegel, F Dehdashti, PW Grigsby - Cancer, 2007 - Wiley Online Library
… The objective of this study was to evaluate cervical tumor uptake of F‐18 … tomography (PET)
and its association with treatment response and prognosis in patients with cervical cancer. …

Cervical cancer: emerging immune landscape and treatment

L Guo, K Hua - OncoTargets and therapy, 2020 - Taylor & Francis
… implicated in controlling tumor growth. In … progression are also tightly correlated with the
immune system. Thus, we discuss immune alteration with cervical lesions and cervical cancer

Functional imaging to predict tumor response in locally advanced cervical cancer

TD Barwick, A Taylor, A Rockall - Current oncology reports, 2013 - Springer
… Worldwide, cervical cancer is the third commonest cancer in women, and although the
incidence has decreased in developed countries following cervical screening, it remains the …

Advances in immunotherapy for cervical cancer: recent developments and future directions

MV Sherer, NV Kotha, C Williamson… - … of Gynecologic Cancer, 2022 - ijgc.bmj.com
… the development of cervical cancer, but probably also influence the response to treatment. …
the treatment of metastatic cervical cancer, particularly for patients with PD-L1 positive tumors. …

Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

C Marth, F Landoni, S Mahner… - Annals of …, 2017 - annalsofoncology.org
… Nearly 90% of cervical cancer deaths occurred in developing parts of the world. The large
geographic variation in cervical cancer rates reflects differences in the availability of screening

Chemotherapy and targeted therapy in the management of cervical cancer

L Kumar, P Harish, PS Malik, S Khurana - Current problems in cancer, 2018 - Elsevier
… stage cervical cancer (IB2 and IIA) appears to be associated with improved response rate
and progression-free survival. However, its impact on overall survival remains to be confirmed. …

Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer

JD Carpini, AK Karam, L Montgomery - Angiogenesis, 2010 - Springer
… plays an important role in the development of cervical cancer. Clinical trials have investigated
… as potential treatment for all three forms of cancer; the data show that in breast cancer, the …

[HTML][HTML] Emerging biological treatments for uterine cervical carcinoma

P Vici, L Mariani, L Pizzuti, D Sergi, L Di Lauro… - … of Cancer, 2014 - ncbi.nlm.nih.gov
… targeting the most relevant pathways involved in cervical cancer development/progression.
Table ​1 reports the results of the main clinical trials with biological agents in advanced …

Cervical cancer therapy: current, future and anti-angiogensis targeted treatment

LJ Willmott, BJ Monk - Expert review of anticancer therapy, 2009 - Taylor & Francis
… on developing countries, with cervical cancer currently … for locally advanced cervical cancer
showed that concomitant … progression-free survival in locally advanced cervical cancer. It …